Advertisement

Topics

FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma

16:09 EDT 14 Sep 2017 | Drugs.com

September 14, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic...

Original Article: FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma"

Quick Search
Advertisement